Citigroup’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
34,043
+27,703
+437% +$86.1K ﹤0.01% 4590
2026
Q1
$14.5K Sell
6,340
-331,592
-98% -$764K ﹤0.01% 4915
2025
Q4
$946K Buy
337,932
+237,315
+236% +$848K ﹤0.01% 3174
2025
Q3
$483K Buy
100,617
+7,058
+8% +$44.9K ﹤0.01% 3598
2025
Q2
$851K Sell
93,559
-14,961
-14% -$110K ﹤0.01% 3282
2025
Q1
$980K Buy
108,520
+2,252
+2% +$23.8K ﹤0.01% 3278
2024
Q4
$1.39M Buy
106,268
+9,838
+10% +$131K ﹤0.01% 3097
2024
Q3
$1.51M Buy
96,430
+39,779
+70% +$603K ﹤0.01% 2913
2024
Q2
$765K Buy
56,651
+2,162
+4% +$44.3K ﹤0.01% 3094
2024
Q1
$1.51M Sell
54,489
-5,537
-9% -$123K ﹤0.01% 2679
2023
Q4
$1.16M Buy
60,026
+19,019
+46% +$344K ﹤0.01% 2698
2023
Q3
$663K Sell
41,007
-31,299
-43% -$555K ﹤0.01% 2843
2023
Q2
$1.38M Buy
72,306
+35,544
+97% +$634K ﹤0.01% 2558
2023
Q1
$535K Sell
36,762
-17,725
-33% -$317K ﹤0.01% 3087
2022
Q4
$1.06M Buy
54,487
+15,722
+41% +$307K ﹤0.01% 2561
2022
Q3
$934K Buy
38,765
+3,107
+9% +$95.7K ﹤0.01% 2781
2022
Q2
$1.12M Sell
35,658
-32,001
-47% -$1.16M ﹤0.01% 2562
2022
Q1
$2.98M Sell
67,659
-224
-0.3% -$9.62K ﹤0.01% 2019
2021
Q4
$2.95M Buy
67,883
+12,109
+22% +$475K ﹤0.01% 2283
2021
Q3
$1.75M Sell
55,774
-10,011
-15% -$394K ﹤0.01% 2645
2021
Q2
$2.79M Sell
65,785
-14,423
-18% -$561K ﹤0.01% 2397
2021
Q1
$3.02M Buy
80,208
+19,269
+32% +$603K ﹤0.01% 2202
2020
Q4
$1.65M Buy
60,939
+14,291
+31% +$368K ﹤0.01% 3046
2020
Q3
$1.17M Buy
46,648
+7,119
+18% +$104K ﹤0.01% 3124
2020
Q2
$301K Sell
39,529
-86,315
-69% -$632K ﹤0.01% 4700
2020
Q1
$1.15M Buy
125,844
+84,914
+207% +$513K ﹤0.01% 3026
2019
Q4
$212K Sell
40,930
-20,076
-33% -$129K ﹤0.01% 5132
2019
Q3
$354K Sell
61,006
-20,124
-25% -$90.3K ﹤0.01% 4661
2019
Q2
$259K Buy
81,130
+16,867
+26% +$57.5K ﹤0.01% 5036
2019
Q1
$264K Sell
64,263
-65,297
-50% -$413K ﹤0.01% 4832
2018
Q4
$820K Buy
129,560
+41,243
+47% +$428K ﹤0.01% 3602
2018
Q3
$1.46M Buy
88,317
+82,825
+1,508% +$1.41M ﹤0.01% 3075
2018
Q2
$91K Buy
5,492
+509
+10% +$8.24K ﹤0.01% 5812
2018
Q1
$77K Sell
4,983
-36,343
-88% -$648K ﹤0.01% 5835
2017
Q4
$781K Buy
41,326
+2,217
+6% +$49.2K ﹤0.01% 3603
2017
Q3
$1.14M Buy
39,109
+19,294
+97% +$570K ﹤0.01% 3231
2017
Q2
$638K Sell
19,815
-8,780
-31% -$288K ﹤0.01% 3764
2017
Q1
$990K Sell
28,595
-195,150
-87% -$6.97M ﹤0.01% 3222
2016
Q4
$7.9M Buy
223,745
+26,542
+13% +$897K 0.01% 1379
2016
Q3
$6.85M Buy
197,203
+42,144
+27% +$1.48M 0.01% 1385
2016
Q2
$5.8M Sell
155,059
-39,447
-20% -$1.48M 0.01% 1446
2016
Q1
$7.86M Sell
194,506
-4,121
-2% -$153K 0.01% 1175
2015
Q4
$7.15M Buy
198,627
+196,611
+9,753% +$7.11M 0.01% 1400
2015
Q3
$64K Sell
2,016
-24,252
-92% -$826K ﹤0.01% 5265
2015
Q2
$893K Buy
26,268
+683
+3% +$23K ﹤0.01% 3237
2015
Q1
$866K Buy
25,585
+4,792
+23% +$167K ﹤0.01% 3227
2014
Q4
$730K Buy
20,793
+17,813
+598% +$600K ﹤0.01% 3466
2014
Q3
$97K Buy
2,980
+2,142
+256% +$72.9K ﹤0.01% 4786
2014
Q2
$28K Sell
838
-81
-9% -$2.77K ﹤0.01% 5609
2014
Q1
$33K Sell
919
-54,482
-98% -$1.92M ﹤0.01% 5754
2013
Q4
$2.03M Buy
55,401
+41,368
+295% +$1.52M ﹤0.01% 2555
2013
Q3
$486K Sell
14,033
-12,497
-47% -$437K ﹤0.01% 3458
2013
Q2
$897K Buy
+26,530
New +$881K ﹤0.01% 2981

Other funds holding ACH

Citigroup's ACH Position: Q2 2026 in Review

Citigroup increased its Accendra Health (ACH) stake by 437% in Q2 2026, buying an estimated $86.1K and bringing the position to 34,043 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #4590.

Citigroup first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.9M in Q4 2016. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Citigroup held 34,043 shares of Accendra Health worth $116K as of Q2 2026.
  • Citigroup bought 27,703 Accendra Health shares in Q2 2026, an estimated $86.1K.
  • Accendra Health made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4590 holding.
  • Citigroup first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's Accendra Health position peaked at $7.9M in Q4 2016.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.